|
?:authorAffiliation
|
-
[\'Duke University Medical Center, Duke Human Vaccine Institute, Durham, NC, USA.\', \'Department of Microbiology and Immunology, Center for AIDS Research, and Children\'s Research Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'3M Corporate Research Materials Laboratory, Saint Paul, MN, USA.\', \'Infectious Disease Research Institute, Seattle, WA, USA.\', \'Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.\', \'Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA, USA.\', \'Moderna, Inc., Cambridge, MA, USA.\', \'California National Primate Research Center, University of California, Davis, CA, USA.\', \'Department of Microbiology and Immunology, Center for AIDS Research, and Children\'s Research Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA abelk@med.unc.edu.\', \'Cornell Weill Medical College, New York, NY, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}